Evidence map›Paper›PMID 42861220›Full record

ArticleQuantitative imaging in medicine and surgery2026

Quantitative dual-energy computed tomography parameters as imaging biomarkers for assessing the histopathologic grade of colorectal cancer.

Tiantian Ma, Jianhua Liu, Meng Wu, Haijia Yu, Siwen Liu, Lihua Gao

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tiantian MaDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.
Jianhua LiuDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.
Meng WuDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.
Haijia YuDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.
Siwen LiuDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.
Lihua GaoDepartment of Radiology, the Second Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0009-0004-9351-2212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) represents a major global healthcare burden. Tumor differentiation grade is a critical prognostic factor for evaluating patients with CRC. The objective of this study was to examine the value of dual-energy computed tomography (DECT) quantitative parameters as imaging biomarkers for the preoperative prediction of histopathologic CRC grade. Methods: A total of 117 patients with pathologically confirmed CRC who underwent preoperative contrast-enhanced DECT were enrolled and divided into low-grade (n=74) and high-grade (n=43) groups. Monoenergetic 74-keV images from the arterial phase (AP), venous phase (VP), and delayed phase (DP) were reconstructed as conventional 120 kVp-like computed tomography (CT) images. Lesion CT attenuation values, iodine concentration (IC), normalized iodine concentration (NIC), effective atomic number (Zeff), and extracellular volume (ECV) were measured in three phases by two radiologists, and clinical data were collected. Intergroup comparisons and Spearman correlation analyses were conducted to determine the associations between spectral parameters and the histopathologic grade of CRC, and multivariable logistic regression analyses were applied to identify independent correlates. Three types of predictive models were established: a baseline model incorporating clinical variables and CT attenuation values, a single spectral parameter model, and combined models integrating clinical features with different spectral parameters. Receiver operating characteristic (ROC) curves and the DeLong test were used to compare the area under the curve (AUC) between the models. Bootstrap internal validation with 1,000 resamples was performed on the optimal model. Results: Serum carcinoembryonic antigen (CEA) concentration showed significant differences between the low-grade group and high-grade group (P=0.009), whereas triphasic 120 kVp-like CT attenuation values showed no statistical differences (P>0.05). For the AP, only IC differed significantly (P=0.011); for the VP and DP, IC, NIC, Zeff, and ECV differed significantly (P<0.05), with ECV showing the strongest correlation with histopathologic grade in CRC (r=0.650: P<0.001). Multivariable analysis identified VP IC [odds ratio (OR) =4.601; P=0.046] and ECV (OR =1.492; P<0.001) as independent correlates of high histopathologic grade in CRC, with AUCs of 0.749 and 0.889, respectively. The integrated model combining clinical indicators with VP and DP spectral parameters achieved the best performance for predicting high histopathologic grade in CRC [AUC =0.904, 95% confidence interval (CI): 0.845-0.962; bias‑corrected AUC =0.904, 95% CI: 0.837-0.954], with an accuracy, sensitivity, and specificity of 85.5%, 88.4%, and 83.8%, respectively. The DeLong test revealed that this integrated model had significantly better diagnostic performance than did the baseline model (AUC =0.538; P<0.001), whereas no statistically significant difference was observed between the integrated model and the VP + DP dual-phase model (P=0.504). Conclusions: DECT quantitative parameters have potential clinical value for predicting the histopathologic grade of patients with CRC. They may serve as imaging biomarkers and provide valuable information for understanding tumor biological behavior.

Indexed as

Colorectal cancer (CRC)dual-energy computed tomography (DECT)histopathologic gradingimaging biomarkersspectral parameters

Identifiers

PMID42861220
PMCPMC13654138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.